Dilution via toxic funding that is so common on the OTC will not happen here.
Dilution will certainly occur in the future. It's silly to think otherwise. But, any dilutive activity will/should be directly related to inventory build up and sales expansion.
He continues to indicate that 5M gross sales is doable this year with a target of at least 50M in the future. Net profits may occur on 5M gross.
With a tiny float very nice movement in the PPS should occur before the EOY 2019 IMO.
Q1 report will be tell tale signs of pending future successes. I'm assuming his order to invoice cycle is still 30 - 60 days. His recent trip to China which was detailed thoroughly on twitter may help this timeline significantly!!
We shall see. Holding tight here. Get em while they're cheap eh!!